Core Viewpoint - Rosen Law Firm is reminding investors who purchased SelectQuote, Inc. securities between September 9, 2020, and May 1, 2025, of the upcoming lead plaintiff deadline on October 10, 2025, for a class action lawsuit [1] Group 1: Class Action Details - Investors who bought SelectQuote securities during the specified period may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [1] - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by the deadline [2] - The lead plaintiff will represent other class members in directing the litigation [2] Group 2: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified counsel with a successful track record in securities class actions [3] - The firm has achieved significant settlements, including the largest securities class action settlement against a Chinese company at the time and has been ranked highly for its performance in securities class action settlements [3] - In 2019, the firm secured over $438 million for investors, showcasing its capability in recovering funds for clients [3] Group 3: Allegations Against SelectQuote - The lawsuit alleges that SelectQuote made false and misleading statements and failed to disclose critical information regarding its business practices [4] - Specific allegations include directing Medicare beneficiaries to insurers that compensated SelectQuote, not providing unbiased comparisons, receiving illegal kickbacks, and non-compliance with laws and regulations [4] - The misleading statements led to investor damages when the true nature of SelectQuote's practices became known [4]

Core Viewpoint - Investors in SelectQuote, Inc. have the opportunity to lead a securities fraud class action lawsuit due to alleged undisclosed practices that misled investors about the company's operations and compliance with regulations [1][2]. Summary by Relevant Sections Lawsuit Details - The lawsuit alleges that from September 9, 2020, to May 1, 2025, SelectQuote failed to disclose critical information, including directing Medicare beneficiaries to plans based on compensation rather than quality [2]. - It is claimed that SelectQuote did not provide unbiased comparisons for Medicare Advantage plans and received illegal kickbacks to steer beneficiaries towards certain insurers [2]. - The company is accused of not complying with applicable laws and regulations, making it vulnerable to legal sanctions, including violations of the False Claims Act [2]. - Positive statements made by the company regarding its business and prospects are alleged to be materially misleading [2]. Participation Information - Investors who suffered losses related to SelectQuote are encouraged to participate in the class action lawsuit before the lead plaintiff deadline of October 10, 2025 [2]. - Interested parties can contact The Law Offices of Frank R. Cruz for more information on participation [3][4].

Core Viewpoint - SelectQuote, Inc. is facing a class action lawsuit due to allegations of receiving illegal kickbacks from health insurance companies, which has led to a significant drop in its stock price [3]. Group 1: Legal Issues - The U.S. Department of Justice filed a False Claims Act complaint against SelectQuote, alleging that from 2016 to at least 2021, the company received "tens of millions of dollars" in illegal kickbacks [3]. - The complaint states that SelectQuote conspired with major insurers to discriminate against less profitable beneficiaries, including those with disabilities [3]. - SelectQuote's claims of providing "unbiased coverage comparisons" were deemed materially false, as the company directed Medicare beneficiaries to plans that paid them the most money [3]. Group 2: Financial Impact - Following the DOJ's announcement, SelectQuote's stock price fell by $0.61 per share, representing a 19.24% decrease, closing at $2.56 per share on May 1, 2025 [3]. Group 3: Investor Actions - The Portnoy Law Firm is advising investors who purchased SelectQuote securities between September 9, 2020, and May 1, 2025, to file a lead plaintiff motion by October 10, 2025 [1]. - Investors are encouraged to contact the Portnoy Law Firm for a complimentary case evaluation and to discuss options for pursuing claims [2].

SAN FRANCISCO--(BUSINESS WIRE)--SelectQuote Inc. (NYSE: SLQT), a digital insurance platform known for selling Medicare Advantage plans, is facing heightened legal scrutiny after the U.S. Department of Justice (DOJ) intervened in a whistleblower lawsuit alleging deceptive sales practices. The federal action triggered a sharp 19% drop in SelectQuote's share price on May 1, 2025, and has now led to a securities class-action lawsuit filed on behalf of investors. The suit, Pahlkotter v. SelectQuote. ...

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In SelectQuote (SLQT) To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in SelectQuote between September 9, 2020 and May 1, 2025 and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212) 355-4648. Click here to participate in the action. NEW YORK, Sept. 29, 2025 (GLOBE NEWSWIRE) -- What’s Happe ...

LOS ANGELES--(BUSINESS WIRE)--SelectQuote, Inc. Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights – SLQT. ...

NEW YORK, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP: Do you, or did you, own shares of SelectQuote, Inc. (NYSE: SLQT)?Did you purchase your shares between September 9, 2020 and May 1, 2025, inclusive?Did you lose money in your investment in SelectQuote, Inc.?Do you want to discuss your rights? Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds SelectQuote, Inc. (“SelectQuote” or the “Company”) (NYSE: SLQT) investors of an upcoming deadline involving a securities ...

Core Viewpoint - Rosen Law Firm is reminding investors who purchased SelectQuote, Inc. securities between September 9, 2020, and May 1, 2025, of the upcoming lead plaintiff deadline on October 10, 2025, for a class action lawsuit [1]. Group 1: Class Action Details - Investors who purchased SelectQuote securities during the specified class period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by the deadline [2]. - The Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions [3]. Group 2: Allegations Against SelectQuote - The lawsuit alleges that SelectQuote made false and misleading statements, including directing Medicare beneficiaries to plans that compensated SelectQuote rather than providing unbiased comparisons [4]. - It is claimed that SelectQuote received illegal kickbacks to steer Medicare beneficiaries to certain insurers, which resulted in non-compliance with applicable laws and regulations [4]. - The lawsuit asserts that the misleading statements about SelectQuote's business operations led to investor damages when the true details became public [4].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased SelectQuote, Inc. securities between September 9, 2020, and May 1, 2025, of the upcoming lead plaintiff deadline on October 10, 2025, for a class action lawsuit [1][2]. Group 1: Class Action Details - Investors who purchased SelectQuote securities during the specified class period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties can join by submitting a form or contacting the law firm [3][6]. - The lead plaintiff must file a motion with the court by October 10, 2025, to represent other class members in the litigation [3]. Group 2: Allegations Against SelectQuote - The lawsuit alleges that SelectQuote made false and misleading statements and failed to disclose critical information, including directing Medicare beneficiaries to plans that compensated SelectQuote rather than providing unbiased comparisons [5]. - It is claimed that SelectQuote received illegal kickbacks to steer Medicare beneficiaries to certain insurers, which resulted in non-compliance with laws and regulations [5]. - The lawsuit asserts that the misleading statements about SelectQuote's business operations led to investor damages when the true details became public [5]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions, highlighting its own achievements in recovering significant settlements for investors [4]. - The firm has been recognized for its performance in securities class action settlements, including being ranked No. 1 by ISS Securities Class Action Services in 2017 and recovering over $438 million for investors in 2019 [4].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased SelectQuote, Inc. securities between September 9, 2020, and May 1, 2025, of the October 10, 2025, deadline to become lead plaintiffs in a class action lawsuit [1] Group 1: Class Action Details - Investors who purchased SelectQuote securities during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1] - A class action lawsuit has already been filed, and interested parties must move the Court by October 10, 2025, to serve as lead plaintiff [2] - The Rosen Law Firm emphasizes the importance of selecting qualified counsel with a successful track record in securities class actions [3] Group 2: Allegations Against SelectQuote - The lawsuit alleges that SelectQuote made false and misleading statements, including directing Medicare beneficiaries to plans that compensated SelectQuote rather than providing unbiased comparisons [4] - It is claimed that SelectQuote received illegal kickbacks to steer Medicare beneficiaries to certain insurers, which resulted in non-compliance with laws and regulations [4] - The lawsuit asserts that the misleading statements about SelectQuote's business led to investor damages when the true details became public [4]